The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic ...

This webinar examines the current landscape of liquid biopsy research and its growing role in cancer detection, monitoring, and treatment decision-making.

Cancer biology is a rapidly evolving field, with pathology and biomarker research at the forefront of innovations in ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

CURE SYNGAP1, a 501(c)(3) organization, is proud to announce the award of a $25,000 grant to Dr. Àlex Bayés Puig, Group ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

Traditional approaches for detecting Alzheimer’s disease (AD) that rely on examining the brain for amyloid plaques have limitations in accuracy and early detection. Although the industry has ...

Real-world data show increasing clinical use of blood-based biomarker panels to monitor disease activity and treatment response in multiple sclerosis.

Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers insights to how these can be overcome. Biomarker exploration has been a ...

Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...